Characterization of novel airway submucosal gland cell models for cystic fibrosis studies

被引:17
作者
da Paula, AC
Ramalho, AS
Farinha, CM
Cheung, J
Maurisse, R
Gruenert, DC
Ousingsawat, J
Kunzelmann, K
Amaral, MD
机构
[1] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA
[2] Natl Inst Hlth Dr Ricardo Jorge, Ctr Human Genet, Lisbon, Portugal
[3] Univ Lisbon, Fac Sci, Dept Chem & Biochem, P-1699 Lisbon, Portugal
[4] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[5] Univ Vermont, Dept Med, Burlington, VT USA
[6] Univ Regensburg, Dept Physiol, D-8400 Regensburg, Germany
关键词
CFTR; cystic fibrosis; CF cellular model; epithelial cells; Calu-3; submucosal gland; airway cell line;
D O I
10.1159/000087235
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cultured airway,epithelial cells are widely used in cystic fibrosis (CF) research as in vitro models that mimic the in vivo manifestations of the disease and help to define a specific cellular phenotype. Recently, a number of in vitro studies have used an airway adenocarcinoma cell line, Calu-3 that expresses submucosal gland cell features and significant levels of the wild-type CFTR mRNA and protein. We further characterized previously described CF tracheobronchial gland cell lines, CFSMEo- and 6CFSMEo- and determined that these cell lines are compound heterozygotes for the F508del and Q2X mutations, produce vestigial amounts of CFTR mRNA, and do not express detectable CFTR protein. Electrophysiologically, both cell lines are characteristically CF in that they lack cAMP-induced Cl- currents. In this study the cell lines are evaluated in the context of their role as the CF correlate to the Calu-3 cells. Together these cell systems provide defined culture systems to study the biology and pathology of CF. These airway epithelial cell lines may also be a useful negative protein control for numerous studies involving gene therapy by cDNA complementation or gene targeting. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:251 / 262
页数:12
相关论文
共 74 条
  • [1] AITKEN ML, 1993, J CLIN INVEST, V91, P225
  • [2] Amaral Margarida D, 2004, J Cyst Fibros, V3 Suppl 2, P17, DOI 10.1016/j.jcf.2004.05.047
  • [3] Liquid secretion properties of airway submucosal glands
    Ballard, ST
    Inglis, SK
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2004, 556 (01): : 1 - 10
  • [4] Decreased expression of the cystic fibrosis transmembrane conductance regulator protein in remodeled airway epithelium from lung transplanted patients
    Brezillon, S
    Hamm, H
    Heilmann, M
    Schafers, HJ
    Hinnrasky, J
    Wagner, TOF
    Puchelle, E
    Tummler, B
    [J]. HUMAN PATHOLOGY, 1997, 28 (08) : 944 - 952
  • [5] ALTERNATE TRANSLATION INITIATION CODONS CAN CREATE FUNCTIONAL FORMS OF CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    CARROLL, TP
    MORALES, MM
    FULMER, SB
    ALLEN, SS
    FLOTTE, TR
    CUTTING, GR
    GUGGINO, WB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) : 11941 - 11946
  • [6] LYMPHOCYTE MESSENGER-RNA AS A RESOURCE FOR DETECTION OF MUTATIONS AND POLYMORPHISMS IN THE CF GENE
    CHALKLEY, G
    HARRIS, A
    [J]. JOURNAL OF MEDICAL GENETICS, 1991, 28 (11) : 777 - 780
  • [7] DEFECTIVE INTRACELLULAR-TRANSPORT AND PROCESSING OF CFTR IS THE MOLECULAR-BASIS OF MOST CYSTIC-FIBROSIS
    CHENG, SH
    GREGORY, RJ
    MARSHALL, J
    PAUL, S
    SOUZA, DW
    WHITE, GA
    ORIORDAN, CR
    SMITH, AE
    [J]. CELL, 1990, 63 (04) : 827 - 834
  • [8] CYSTIC-FIBROSIS - MOLECULAR-BIOLOGY AND THERAPEUTIC IMPLICATIONS
    COLLINS, FS
    [J]. SCIENCE, 1992, 256 (5058) : 774 - 779
  • [9] *CONS TCFGA, 1990, AM J HUM GENET, P47
  • [10] COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735